mebendazole has been researched along with Esophageal Diseases in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Esophageal Diseases: Pathological processes in the ESOPHAGUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marcos Sánchez, F | 1 |
| Aparicio Martínez, JC | 1 |
| Moreno Palomares, M | 1 |
| Durán Pérez-Navarro, A | 1 |
1 other study available for mebendazole and Esophageal Diseases
| Article | Year |
|---|---|
[Esophageal and gastric ascariasis].
Topics: Animals; Antacids; Antinematodal Agents; Ascariasis; Ascaris lumbricoides; Esophageal Diseases; Fema | 1997 |